Company profile: Dadi
1.1 - Company Overview
Company description
- Provider of at-home sperm collection kits, male fertility reports, and sperm storage, offering a clinic-free option directly to men: $99 for the kit and fertility report, then $99 per year for storage.
Products and services
- Male Fertility Report: Quantitative report that details sperm test results
- Bundled with the $99 kit, offering clear insights directly to men without clinic visits
- Sperm Kit: At-home collection and testing kit that enables men to collect a sample without clinic visits
- $99 includes kit and fertility report
- Sperm Storage: Subscription-based service that stores sperm for future use at $99 per year, delivering a modern, accessible option directly to men without clinic appointments.
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Dadi
Polyganics
HQ: The Netherlands
Website
- Description: Provider of bioresorbable medical devices for natural tissue repair and regeneration, developing, manufacturing, and marketing products including LIQOSEAL dura sealant patch for watertight dural closure; dental and bone grafting materials such as GUIDOR easy-graft, MatrixDerm, MatrixOss Granules, and SynOss Putty; and dural repair solutions like DuraMatrix-Onlay Plus.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Polyganics company profile →
Amnis
HQ: United States
Website
- Description: Provider of flow cytometry products and services used in research and clinical studies, including investigating the immune system in fighting cancer, diagnosing leukemia and lymphoma, and detecting minimal residual disease in organ transplant. Offers Cytek Aurora spectral cytometer, Aurora CS cell sorter, Northern Lights, Orion reagent prep, ESP Detection Option, and Cytek Amnis AI v3.0 image analysis software.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Amnis company profile →
Camurus
HQ: Sweden
Website
- Description: Provider of innovative specialty medicines, with research-based development and commercialization aimed at improving treatment outcomes and quality of life for patients with serious and chronic diseases; based in Lund.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Camurus company profile →
BBI Group
HQ: United Kingdom
Website
- Description: Provider of diagnostic products to multiple industries, founded on superior gold reagents. A trusted partner to leading diagnostic and healthcare organisations for over 25 years, with three businesses delivering excellence in diagnostic assay development and manufacturing.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full BBI Group company profile →
Double Rainbow Biosciences
HQ: United States
Website
- Description: Provider of sustainable supply of active pharmaceutical ingredients; access to rare or endangered ingredients for consumer health products; bioengineering solutions for ag tech addressing global food insecurity; PRISM enzyme modification platform to improve specificity and efficacy of medicines via glycosylation; HARMONY molecular biosynthesis platform for sustainable recreation of bioactive compounds; and biosynthetic production of Gastrodin.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Double Rainbow Biosciences company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Dadi
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Dadi
2.2 - Growth funds investing in similar companies to Dadi
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Dadi
4.2 - Public trading comparable groups for Dadi
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →